Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.86 USD | +16.26% | +28.12% | +129.60% |
Apr. 16 | Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study | MT |
Apr. 16 | Lexaria Bioscience Corp. Receives Ethics Review Board Approval to Begin New GLP-1 Study | CI |
- Stock Market
- Equities
- LEXX Stock
- News Lexaria Bioscience Corp.
- MarketScreener Editorial Features